Evidence map›Paper›PMID 42666302›Full record

ArticleFrontiers in public health2026

Evaluating economic and health-system associations of a national public health legal framework: evidence from China's basic medical and health care and health promotion law.

Peiran Lu

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Peiran LuBeijing Foreign Studies University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Framework health legislation is increasingly used to codify government responsibility, health-promotion duties, and accountability for basic services, yet it is difficult to identify whether such laws produce measurable economic and health effects. China's Basic Medical and Health Care and Health Promotion Law, effective June 2020, consolidated these duties in a single national statute. Methods: Using a province-year panel for 31 mainland provinces over 2015-2022 compiled from public statistical yearbooks, we evaluate the law with a differential-bindingness difference-in-differences (DID) design: because the statute applies nationwide, treatment is defined Results: The most consistent association is a relative post-law decline in emergency case-fatality in high-bindingness provinces (about -0.03 percentage points, Conclusion: We find suggestive, definition-sensitive evidence that framework health law may be associated with modest differential gains in some service-quality outcomes where pre-law capacity was weaker. Still, the data cannot support strong causal claims, and post-law shifts cannot be fully separated from province-specific COVID-19 dynamics. The contribution is a transparent, reproducible evaluation scaffold and a cautionary finding: detecting the economic effects of health legislation requires better subnational outcome reporting, especially maternal and infant mortality.

Indexed as

Delivery of Health CareHealth PromotionPublic HealthChinaCOVID-19HumansSARS-CoV-2China health policydifference-in-differenceshealth economicslegal determinants of healthpolicy evaluationpublic health law

Identifiers

PMID42666302
PMCPMC13522156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.